| The future landscape of large language models in medicine J Clusmann, FR Kolbinger, HS Muti, ZI Carrero, JN Eckardt, NG Laleh, ... Communications medicine 3 (1), 141, 2023 | 374 | 2023 |
| Application of machine learning in the management of acute myeloid leukemia: current practice and future prospects JN Eckardt, M Bornhäuser, K Wendt, JM Middeke Blood Advances 4 (23), 6077-6085, 2020 | 68 | 2020 |
| Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears JN Eckardt, JM Middeke, S Riechert, T Schmittmann, AS Sulaiman, ... Leukemia 36 (1), 111-118, 2022 | 66 | 2022 |
| Reinforcement learning for precision oncology JN Eckardt, K Wendt, M Bornhaeuser, JM Middeke Cancers 13 (18), 4624, 2021 | 56 | 2021 |
| The multimodality cell segmentation challenge: toward universal solutions J Ma, R Xie, S Ayyadhury, C Ge, A Gupta, R Gupta, S Gu, Y Zhang, G Lee, ... Nature methods, 1-11, 2024 | 52 | 2024 |
| Deep learning identifies acute promyelocytic leukemia in bone marrow smears JN Eckardt, T Schmittmann, S Riechert, M Kramer, AS Sulaiman, K Sockel, ... BMC cancer 22 (1), 201, 2022 | 40 | 2022 |
| An overview and a roadmap for artificial intelligence in hematology and oncology W Rösler, M Altenbuchinger, B Baeßler, T Beissbarth, G Beutel, R Bock, ... Journal of cancer research and clinical oncology 149 (10), 7997-8006, 2023 | 39 | 2023 |
| Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations JN Eckardt, F Stölzel, D Kunadt, C Röllig, S Stasik, L Wagenführ, ... Journal of Hematology & Oncology 15 (1), 60, 2022 | 38 | 2022 |
| Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia S Stasik, JN Eckardt, M Kramer, C Röllig, A Krämer, S Scholl, A Hochhaus, ... Blood advances 5 (17), 3279-3289, 2021 | 32 | 2021 |
| Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study JM Middeke, KH Metzeler, C Röllig, M Krämer, JN Eckardt, S Stasik, ... Blood advances 6 (5), 1394-1405, 2022 | 26 | 2022 |
| Semi-supervised learning in cancer diagnostics JN Eckardt, M Bornhäuser, K Wendt, JM Middeke Frontiers in oncology 12, 960984, 2022 | 24 | 2022 |
| GPT-4 for Information Retrieval and Comparison of Medical Oncology Guidelines D Ferber, IC Wiest, G Wölflein, MP Ebert, G Beutel, JN Eckardt, D Truhn, ... NEJM AI 1 (6), AIcs2300235, 2024 | 19 | 2024 |
| Large language models and multimodal foundation models for precision oncology D Truhn, JN Eckardt, D Ferber, JN Kather NPJ Precision Oncology 8 (1), 72, 2024 | 17 | 2024 |
| Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome JN Eckardt, S Stasik, C Röllig, T Sauer, S Scholl, A Hochhaus, M Crysandt, ... Blood Cancer Journal 13 (1), 18, 2023 | 17 | 2023 |
| Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning JN Eckardt, C Röllig, K Metzeler, M Kramer, S Stasik, JA Georgi, P Heisig, ... Haematologica 108 (3), 690, 2022 | 17 | 2022 |
| Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification JN Eckardt, M Bill, C Rausch, K Metzeler, K Spiekermann, S Stasik, ... Leukemia 37 (11), 2282-2285, 2023 | 12 | 2023 |
| Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence JN Eckardt, W Hahn, C Röllig, S Stasik, U Platzbecker, C Müller-Tidow, ... NPJ digital medicine 7 (1), 76, 2024 | 11 | 2024 |
| Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles JN Eckardt, C Röllig, K Metzeler, P Heisig, S Stasik, JA Georgi, ... Communications Medicine 3 (1), 68, 2023 | 10 | 2023 |
| Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia JN Eckardt, S Stasik, M Kramer, C Röllig, A Krämer, S Scholl, A Hochhaus, ... Cancers 13 (9), 2095, 2021 | 10 | 2021 |
| UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome JA Georgi, S Stasik, JN Eckardt, S Zukunft, M Hartwig, C Röllig, ... Blood Cancer Journal 13 (1), 88, 2023 | 8 | 2023 |
